
Damita M 5mg/500mg Tablet ER
Marketer
Macleods Pharmaceuticals Pvt Ltd
Salt Composition
Dapagliflozin (5mg) + Metformin (500mg)
Overview Damita M 5mg/500mg Tablet ER
Diabetic patients with type 2 mellitus may find relief with Damita M 5mg/500mg Extended-Release tablets, a dual-medication formulation. This combination effectively manages elevated blood glucose, mitigating the risk of severe diabetic complications, including cardiovascular issues. Consume Damita M with meals, adhering to a consistent daily schedule for optimal adherence. Dosage is determined by your physician; discontinuation requires their approval to avoid uncontrolled blood sugar spikes and potential harm such as kidney disease and vision loss. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight control as recommended by your doctor. Commonly reported side effects include upper respiratory symptoms (sore throat, nasal congestion, rhinorrhea), headache, gastrointestinal upset (nausea, vomiting, diarrhea). Adequate hydration is essential to minimize dehydration. Genital fungal infections are a potential side effect; practicing good hygiene is preventative. Prior to initiating treatment, disclose any pre-existing conditions such as kidney or liver impairment, urinary tract infections, or diuretic use to your doctor. Pregnant or lactating individuals require medical consultation before use. Limit alcohol consumption as it could intensify side effects. Regular blood glucose monitoring is crucial throughout treatment.
Primary Ingredients of Damita M 5mg/500mg Tablet ER
There is no text provided to rephrase.
Uses of Damita M 5mg/500mg Tablet ER
Managing Type 2 Diabetes
Major Benefits of Damita M 5mg/500mg Tablet ER:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the entire tablet without chewing, crushing, or fracturing it. The Damita M 5mg/500mg Extended-Release tablet should be taken with a meal.
Common Side effects of Damita M 5mg/500mg Tablet ER:
- Nausea
- Vomiting
- Diarrhea
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
- Polyuria
- Flatulence
- Skin rash
- Taste change
- Difficulty in urination
- Hypoglycemia (low blood glucose level)
- Tremors
- Dizziness
- Back pain
- Increased hematocrit
- Decreased creatinine clearance
- Dyslipidemia
How to use Damita M 5mg/500mg Tablet ER:
Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the entire tablet without chewing, crushing, or breaking it. The Damita M 5mg/500mg Extended-Release tablet should be taken with a meal.
How Damita M 5mg/500mg Tablet ER works:
Damita M 5mg/500mg Extended-Release tablets combine dapagliflozin and metformin to manage blood glucose levels. Dapagliflozin facilitates urinary glucose excretion, while metformin reduces hepatic glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. This dual action leads to improved glycemic control.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of alcohol and Damita M 5mg/500mg extended-release tablets is contraindicated.
PregnancyCONSULT YOUR DOCTOR
The extended-release Damita M 5mg/500mg tablet might pose risks during pregnancy. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing it. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Damita M 5mg/500mg tablets are likely not safe for breastfeeding mothers. Preliminary human data indicate potential drug transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if you experience such symptoms.
KidneyCAUTION
Patients with impaired kidney function should use Damita M 5mg/500mg Extended-Release tablets cautiously. Dosage modification may be necessary; physician consultation is advised.
LiverCAUTION
Patients with liver impairment should exercise caution when using Damita M 5mg/500mg extended-release tablets. Dosage modification of Damita M 5mg/500mg extended-release tablets may be necessary. Physician consultation is advised.
What if you forget to take Damita M 5mg/500mg Tablet ER :
Should you forget a Damita M 5mg/500mg Extended-Release Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Damita M 5mg/500mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
